Panagiotis F. Christopoulos

  • Postdoctoral fellow
  • +47 23 07 35 37

Office: RH A3.M026


Original articles

Müller E, Speth M, Christopoulos PF, Lunde A, Avdagic A, Øynebråten I, Corthay A (2018)
Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
Front Immunol, 9, 2520
DOI 10.3389/fimmu.2018.02520, PubMed 30450098

Kurena B, Müller E, Christopoulos PF, Johnsen IB, Stankovic B, Øynebråten I, Corthay A, Zajakina A (2017)
Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γ
Front Immunol, 8, 1667
DOI 10.3389/fimmu.2017.01667, PubMed 29276511

Müller E, Christopoulos PF, Halder S, Lunde A, Beraki K, Speth M, Øynebråten I, Corthay A (2017)
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
Front Immunol, 8, 1383
DOI 10.3389/fimmu.2017.01383, PubMed 29123526

Christopoulos PF, Papageorgiou E, Petraki C, Koutsilieris M (2017)
The COOH-terminus of the IGF-1Ec Isoform Enhances the Proliferation and Migration of Human MCF-7 Breast Cancer Cells
Anticancer Res, 37 (6), 2899-2912
DOI 10.21873/anticanres.11643, PubMed 28551627

Papageorgiou E, Philippou A, Armakolas A, Christopoulos PF, Dimakakos A, Koutsilieris M (2016)
The human Ec peptide: the active core of a progression growth factor with species-specific mode of action
Hormones (Athens), 15 (3), 423-434
DOI 10.14310/horm.2002.1699, PubMed 27838607

Christopoulos PF, Bournia VK, Panopoulos S, Vaiopoulos A, Koutsilieris M, Sfikakis PP (2015)
Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement
Clin Exp Rheumatol, 33 (4 Suppl 91), S36-9
PubMed 26121083

Christopoulos PF, Philippou A, Koutsilieris M (2015)
Pattern of IGF-1 variants' expression in human cancer cell lines using a novel q-RT-PCR approach
Anticancer Res, 35 (1), 107-15
PubMed 25550540

Review articles

Christopoulos PF, Corthay A, Koutsilieris M (2017)
Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics
Cancer Treat Rev, 63, 79-95
DOI 10.1016/j.ctrv.2017.11.010, PubMed 29253837

Christopoulos PF, Vlachogiannis NI, Vogkou CT, Koutsilieris M (2017)
The Role of the Androgen Receptor Signaling in Breast Malignancies
Anticancer Res, 37 (12), 6533-6540
DOI 10.21873/anticanres.12109, PubMed 29187427

Sfikakis PP, Vlachogiannis NI, Christopoulos PF (2017)
Cadherin-11 as a therapeutic target in chronic, inflammatory rheumatic diseases
Clin Immunol, 176, 107-113
DOI 10.1016/j.clim.2017.01.008, PubMed 28115292

Philippou A, Christopoulos PF, Koutsilieris DM (2016)
Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer
Mutat Res Rev Mutat Res, 772, 105-122
DOI 10.1016/j.mrrev.2016.09.005, PubMed 28528684

Christopoulos PF, Msaouel P, Koutsilieris M (2015)
The role of the insulin-like growth factor-1 system in breast cancer
Mol Cancer, 14, 43
DOI 10.1186/s12943-015-0291-7, PubMed 25743390

Christoforou P, Christopoulos PF, Koutsilieris M (2014)
The role of estrogen receptor β in prostate cancer
Mol Med, 20, 427-34
DOI 10.2119/molmed.2014.00105, PubMed 25032955

Other articles

Christopoulos PF, Sfikakis PP, Nikolaou E, Terpos E, Koutsilieris M, Kyrtsonis MC (2016)
Cadherin-11 (CDH11) expression in the peripheral blood of patients with active Multiple Myeloma
Br J Haematol, 177 (5), 813-816
DOI 10.1111/bjh.14105, PubMed 27118219

Page visits: 1926